Skip to main content

Advertisement

Log in

Clinical Oncology/Epidemiology

Verification of the cause of death in the trial of early detection of breast cancer

  • Clinical Oncology/Epidemiology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

The limitations of case review as a means of identifying errors in death certificates among breast cancer patients in a non-randomised trial of screening are illustrated by the findings of this large study. Records of 928 out of 990 deaths were available for review but were very variable in quality. Definite errors were found in 1%, errors were suspected in a further 5% and uncertainty about the cause of death, despite review, was recorded for 27%. The overall bias in reporting breast cancer deaths was less than 1%. It was concluded that the certified underlying cause of death without review provides an adequate endpoint for evaluating breast cancer screening programmes in the UK.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chamberlain, J., Coleman, D., Ellman, R. et al. Verification of the cause of death in the trial of early detection of breast cancer. Br J Cancer 64, 1151–1156 (1991). https://doi.org/10.1038/bjc.1991.480

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1991.480

  • Springer Nature Limited

This article is cited by

Navigation